Sex difference in tolerability of adjuvant oxaliplatin-based chemotherapy for colorectal cancer and changes in diagnostic components of sarcopenia: A prospective study

被引：0
|
作者：
Nozawa, Hiroaki
Abe, Shinya
Abe, Kentaro
Yokota, Yumi
Yakabe, Mitsutaka
Akishita, Masahiro
Ishihara, Soichiro
机构：
[1] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
[2] Univ Tokyo, Dept Geriatr Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
日本学术振兴会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15625
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Multiple Liver Lesions After Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Shlomai, Amir
    Tobar, Ana
    Benjaminov, Ofer
    GASTROENTEROLOGY, 2015, 149 (06) : E1 - E3
  • [22] Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Gill, Sharlene
    Lim, Howard John
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy
    Hesketh, P. J.
    Sanz-Altamira, P.
    Bushey, J.
    Malek, K.
    Insalaco, L.
    Hesketh, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy
    Hesketh, Paul J.
    Sanz-Altamira, Pedro
    Bushey, Julie
    Hesketh, Ann M.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 1043 - 1047
  • [25] Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy
    Paul J. Hesketh
    Pedro Sanz-Altamira
    Julie Bushey
    Ann M. Hesketh
    Supportive Care in Cancer, 2012, 20 : 1043 - 1047
  • [26] Evaluation of the CpG island methylator phenotype as a predictive biomarker for adjuvant oxaliplatin-based chemotherapy in colorectal cancer.
    Shiovitz, Stacey
    Wu, Chen
    Yu, Ming
    Gourgioti, Georgia
    Raptou, Georgia
    Kotoula, Vassiliki
    Pentheroudakis, George E.
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [27] Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel
    Kennecke, Hagen F.
    Lim, Howard J.
    Cheung, Winson Y.
    Melosky, Barbara
    Gill, Sharlene
    CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 25 - 30
  • [28] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Peter H Cashin
    Lana Ghanipour
    Malin Enblad
    David L Morris
    World Journal of Gastrointestinal Oncology, 2020, (05) : 549 - 558
  • [29] Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study
    Tugral, Alper
    Kebabci, Eyup
    Aribas, Zeynep
    Akyol, Murat
    Can, Aysegul
    Bakar, Yesim
    SUPPORTIVE CARE IN CANCER, 2024, 32 (11)
  • [30] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Morris, David L.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (05) : 549 - 558
12345